What's Happening?
A systematic review has analyzed the existing human and experimental evidence linking the oral bacterium *Fusobacterium nucleatum* to endometriosis. The review, which included four human studies with 384 participants, found that direct tissue evidence regarding
the presence of *F. nucleatum* in endometrial or endometriotic tissue is conflicting. One study reported frequent detection of *Fusobacterium* in a subset of endometrial and endometriotic tissues from Japanese patients, while another found no significant difference in *F. nucleatum* abundance between cases and controls. The remaining studies provided indirect evidence from non-tissue microbial communities, such as oral, vaginal, rectal, or stool samples, which cannot definitively establish tissue colonization or translocation. All human studies were assessed to have a serious overall risk of bias, and the certainty of evidence was rated as very low.
Why It's Important?
Endometriosis affects approximately 190 million women worldwide, causing chronic pelvic pain, dysmenorrhea, dyspareunia, and infertility, significantly impacting quality of life. Understanding its pathogenesis is crucial for developing effective treatments. The potential involvement of microorganisms like *F. nucleatum* in endometriosis could open new avenues for diagnosis and therapy. However, the current inconsistent findings mean that *F. nucleatum* cannot yet be considered a confirmed causal factor or a reliable therapeutic target. This lack of clear evidence prevents the recommendation of antibiotic treatments for endometriosis based on presumed *F. nucleatum* involvement, which is important for public health to avoid unnecessary antimicrobial exposure, potential resistance, and disruption of beneficial microbial communities. The review highlights the need for more rigorous and standardized research to establish any definitive link.
What's Next?
Future research needs to prioritize standardized and contamination-aware approaches to determine if *F. nucleatum* is consistently associated with endometriosis. This includes clearly defining anatomical sampling locations, menstrual-cycle phases, collection procedures, and recent antibiotic exposure, along with appropriate negative and environmental controls. Prospective studies should collect paired oral and reproductive-tract samples, ideally with strain-level genomic analyses, to determine if genetically related *F. nucleatum* strains are present in both sites, which would provide stronger evidence for dissemination routes. Longitudinal studies are also essential to establish temporality, determining whether *F. nucleatum* presence precedes lesion development or is a consequence of the disease. Independent replication of experimental findings, such as the proposed TGF-β-mediated mechanism, is also crucial. Only after a reproducible bacterial association and a clinically relevant mechanistic role are established should targeted antimicrobial interventions be evaluated in randomized controlled trials.
Beyond the Headlines
The ongoing investigation into the role of the microbiome in chronic diseases like endometriosis represents a significant paradigm shift in medical research. The concept of an 'endobiota' challenges the traditional view of certain body sites as sterile, suggesting that microbial communities may influence local inflammation, immune dysregulation, and tissue remodeling. This systematic review, despite its inconclusive findings, contributes to the broader scientific effort to understand the complex interplay between host and microbes. It also underscores the methodological challenges inherent in microbiome research, particularly in low-biomass samples where contamination can easily skew results. The cautious approach to antibiotic use, emphasized by the review, reflects a growing awareness of antimicrobial stewardship and the potential ecological impact of broad-spectrum treatments on the human microbiome, even as researchers explore microbial contributions to disease.
